Poewe, Werner
Seppi, Klaus
Tanner, Caroline M.
Halliday, Glenda M.
Brundin, Patrik
Volkmann, Jens
Schrag, Anette-Eleonore
Lang, Anthony E.
Article History
First Online: 23 March 2017
Competing interests
: W.P. reports personal fees from AbbVie, Allergan, AstraZeneca, BIAL, Boehringer-Ingelheim, Boston Scientific, GlaxoSmithKline, Ipsen, Lundbeck, Medtronic, MSD, Merck-Serono, Merz Pharmaceuticals, Neuroderm, Novartis, Orion Pharma, Teva, UCB and Zambon (consultancy and lecture fees in relation to clinical drug development programmes for Parkinson disease) and publishing royalties from Thieme, Wiley-Blackwell, Oxford University Press and Cambridge University Press. K.S. reports personal fees from Boehringer-Ingelheim, UCB, Lundbeck, AbbVie, Roche, Teva and AOP Orphan Pharmaceuticals AG. C.M.T. has received compensation for serving on Data Monitoring Committees from Biotie Therapeutics, Voyager Therapeutics and Intec Pharma and personal fees for consulting services from Ultragenyx Pharmaceuticals, Neurocrine Biosciences, Cynapsus, Therapeutics, Sage Bionetworks and Adamas. G.M.H. has received compensation for serving on data monitoring committees from Biotie Therapeutics, Voyager Therapeutics and Intec Pharma, and personal fees from the American Academy of Neurology, Bionomics and Lundbeck. P.B. has received commercial support as a consultant from Renovo Neural, Roche, Teva, Lundbeck, AbbVie, Neuroderm, Versant Ventures/Apollo and IOS Press Partners. J.V. reports personal fees from Boston Scientific, Medtronic, Bial, Allergan, Zambon (consultancy and lecture fees in relation to clinical therapeutic development programmes for Parkinson disease) and grants from Boston Scientific and Medtronic. A.-E.S. reports grants from, Parkinson's UK, GE Healthcare, International Parkinson and Movement Disorder Society, shares from AstraZeneca, and personal fees from Grunenthal, Medtronic and Oxford University Press. A.E.L. reports personal fees from AbbVie, Acorda, Avanir Pharmaceuticals, Bristol-Myers Squibb, Cipla, Intekrin, Sun Pharma, Medichem, Medtronic, Teva, UCB and Merck, and publishing royalties from Saunders, Wiley-Blackwell, Johns Hopkins Press and Cambridge University Press.